Skip to main page content
U.S. flag

An official website of the United States government

Dot gov

The .gov means it’s official.
Federal government websites often end in .gov or .mil. Before sharing sensitive information, make sure you’re on a federal government site.

Https

The site is secure.
The https:// ensures that you are connecting to the official website and that any information you provide is encrypted and transmitted securely.

Access keys NCBI Homepage MyNCBI Homepage Main Content Main Navigation

Search Page

Filters

My Custom Filters

Publication date

Text availability

Article attribute

Article type

Additional filters

Article Language

Species

Sex

Age

Other

Search Results

3,227 results

Filters applied: . Clear all
Results are displayed in a computed author sort order. The Publication Date timeline is not available.
Page 1
Nosema ceranae in South American Native Stingless Bees and Social Wasp.
Porrini MP, Porrini LP, Garrido PM, de Melo E Silva Neto C, Porrini DP, Muller F, Nuñez LA, Alvarez L, Iriarte PF, Eguaras MJ. Porrini MP, et al. Among authors: muller f. Microb Ecol. 2017 Nov;74(4):761-764. doi: 10.1007/s00248-017-0975-1. Epub 2017 Apr 7. Microb Ecol. 2017. PMID: 28389730
Immune-checkpoint-inhibitor therapy directed against PD-L1 is tolerated in the heart without manifestation of cardiac inflammation in a preclinical reversible melanoma mouse model.
Schoenherr C, Pietzsch S, Barca C, Müller FE, Bahr FS, Kasten M, Zeug A, Erschow S, Falk CS, Ponimaskin E, Thackeray JT, Hilfiker-Kleiner D, Ricke-Hoch M. Schoenherr C, et al. Among authors: muller fe. Front Mol Med. 2025 Jan 6;4:1487526. doi: 10.3389/fmmed.2024.1487526. eCollection 2024. Front Mol Med. 2025. PMID: 39834851 Free PMC article.
Idecabtagene vicleucel or ciltacabtagene autoleucel for relapsed or refractory multiple myeloma: An international multicenter study.
Merz M, Albici AM, von Tresckow B, Rathje K, Fenk R, Holderried T, Müller F, Tovar N, Oliver-Cáldes A, Vucinic V, Kharboutli S, Bärmann BN, Ayuk F, Platzbecker U, Stölzel F, Schub N, Schmitz F, Fandrei D, Born P, Khandanpour C, Hanoun C, Hörster K, Teichert M, Jeker B, Hoffmann M, Kröger N, de Larrea CF, Pabst T, Gagelmann N. Merz M, et al. Among authors: muller f. Hemasphere. 2025 Jan 16;9(1):e70070. doi: 10.1002/hem3.70070. eCollection 2025 Jan. Hemasphere. 2025. PMID: 39822585 Free PMC article.
Impaired Hepatitis B and COVID-19 vaccination responses show strong concordance in hemodialysis patients with end stage renal disease.
Lürken K, Meinecke A, Manthey LA, Cossmann A, Stankov MV, Klawonn F, Zychlinsky Scharff A, Steffens S, Dopfer-Jablonka A, Müller F, Behrens GMN, Happle C. Lürken K, et al. Among authors: muller f. Eur J Med Res. 2025 Jan 16;30(1):34. doi: 10.1186/s40001-025-02274-3. Eur J Med Res. 2025. PMID: 39819737 Free PMC article.
Autogene cevumeran with or without atezolizumab in advanced solid tumors: a phase 1 trial.
Lopez J, Powles T, Braiteh F, Siu LL, LoRusso P, Friedman CF, Balmanoukian AS, Gordon M, Yachnin J, Rottey S, Karydis I, Fisher GA, Schmidt M, Schuler M, Sullivan RJ, Burris HA, Galvao V, Henick BS, Dirix L, Jaeger D, Ott PA, Wong KM, Jerusalem G, Schiza A, Fong L, Steeghs N, Leidner RS, Rittmeyer A, Laurie SA, Gort E, Aljumaily R, Melero I, Sabado RL, Rhee I, Mancuso MR, Muller L, Fine GD, Yadav M, Kim L, Leveque VJP, Robert A, Darwish M, Qi T, Zhu J, Zhang J, Twomey P, Rao GK, Low DW, Petry C, Lo AA, Schartner JM, Delamarre L, Mellman I, Löwer M, Müller F, Derhovanessian E, Cortini A, Manning L, Maurus D, Brachtendorf S, Lörks V, Omokoko T, Godehardt E, Becker D, Hawner C, Wallrapp C, Albrecht C, Kröner C, Tadmor AD, Diekmann J, Vormehr M, Jork A, Paruzynski A, Lang M, Blake J, Hennig O, Kuhn AN, Sahin U, Türeci Ö, Camidge DR. Lopez J, et al. Among authors: muller f. Nat Med. 2025 Jan;31(1):152-164. doi: 10.1038/s41591-024-03334-7. Epub 2025 Jan 6. Nat Med. 2025. PMID: 39762422 Free PMC article. Clinical Trial.
3,227 results